: ENO1 gene silencing in a panel of human cancer cells. Western blot analysis of ENO1 (left panels), all enolase isoforms (assessed by using a pan-enolase polyclonal antibody, middle left panels) and c-Myc expression (middle panels) in CFPAC-1 (A) PT45 (B) T3M4 (C) MDA-MB-231 (D) and NCI-H441 (E) non-transduced (parental) and stably transduced with an shRNA targeting ENO1 (shENO1) or a scrambled shRNA (shCTRL) as a control. β-actin was used as loading control. qRT-PCR analysis (middle right panels) of ENO1, ENO2, ENO3 and c-Myc and analysis of enolase activity measured as the rate of NADH oxidation (right panels) in CFPAC-1 (A), PT45 (B), T3M4 (C), MDA-MB-231 (D) and NCI-H441 (E) shCTRL and shENO1 cells. Results are the mean of three independent experiments ± SEM of triplicates. ***p < 0.001 relative to shCTRL. ENO1 knockdown also affects ENO2 and ENO3 expression, most probably through post-translational mechanisms, as ENO2 and ENO3 mRNA was unaffected. The expression of c-Myc, which is transcriptionally repressed by the ENO1 alternative transcript MBP-1, was not influenced by ENO1 knockdown, ruling out any functional effects related to this gene in ENO1-silenced cells.
Supplementary Figure S2: The polyol and pentose phosphate pathways increase the concentration of intracellular reactive oxygen species (ROS) in ENO1-silenced cells. (A) Heat map of differentially-expressed proteins in shENO1 compared
to shCTRL CFPAC-1 cells. Based on the spectra count label-free quantitation approach, LC-MS/MS analysis identified 32 up-regulated (red) and 28 down-regulated (green) proteins. Proteins are classified according to their function: cell cycle/signaling, protein transport, protein biosynthesis, cell adhesion/migration and others/unknown. See also Figure 1A for other identified proteins. (B-C) Analysis of aldose reductase (ALDR) activity measured as the rate of NADPH oxidation (B), and NADPH oxidase activity assessed by the isoluminolchemiluminescence assay (C) in shCTRL and shENO1 PT45 and T3M4 cell lines. Chemiluminescence was expressed as relative luminescence unit (RLU)/mg cell proteins. (D-E) Analysis of ROS concentration measured by DCFDA-AM assay (D) and of [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] C] glucose flux through the Pentose Phosphate Pathway (PPP) assessed through 14 CO 2 release (E) after selective inhibition of mitochondrial chain (rotenone), NADPH oxidase (apocynin) and ALDR (zopolrestat) in shCTRL and shENO1 PT45 (left panels) and T3M4 (right panels) cell lines. (F) Analysis of PPP activity, as described above, after selective inhibition of the PPP (DHEA) in CFPAC-1 (left panels), MDA-MB-231 (middle panel) and NCI-H441 (right panel) cell lines. All the graphs illustrate the mean result of three independent experiments ± SEM *p < 0.05; **p < 0.01;***p < 0.001 relative to shCTRL.
Supplementary Figure S3: mRNA expression analysis of mass spectrometry identified proteins. (A-B) Transcript analysis
of proteins identified as up-regulated or down-regulated through semi-quantitative tandem mass spectrometry analysis in CFPAC-1 (red), PT45 (orange), T3M4 (purple), MDA-MB-231 (blue) and NCI-H441 (green) shENO1 compared to shCTRL (white) cells. Genes were divided according to their function: glycolysis-related (A) and catabolic pathways (B). Results are the mean ± SEM of triplicates. *p < 0.05; **p < 0.01;***p < 0.001 relative to shCTRL-transduced cells. See Table S2 and S3 for extended gene names.
Supplementary Figure S4: ENO1 silencing enhances catabolic pathway adaptations.
(A-C) Cells were exposed to [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] C] palmitic acid and total palmitate oxidation (sum of 14 C-acid soluble metabolites and 14 CO 2 production) of palmitic acid in shCTRL and shENO1 PT45 and T3M4 cell lines (A) was measured.
14 C-acid soluble metabolites production (B) and 14 CO 2 production (C) were measured in shCTRL and shENO1 CFPAC-1, PT45, T3M4, MDA-MB-231 and NCI-H441 cell lines. (D-E) Analysis of phenylalanine (D) and acetoacetate (E) concentration in shCTRL and shENO1 PT45 and T3M4 cell lines. (F) The TCA cycle rate was evaluated measuring CO 2 emission after radiolabelling cells with [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] C] acetylcoenzyme A in shCTRL and shENO1 PT45 and T3M4 cell lines. All the graphs illustrate the mean result of three independent experiments ± SEM *p < 0.05; **p < 0.01;***p < 0.001 relative to shCTRL. (G) Schematic diagram of ENO1 silencing-induced catabolic pathway adaptations.
Supplementary Figure S5: ENO1 knockdown promotes oxidative phosphorylation. (A-C) Analysis of glutaminase (GLS)
(A), glutamine amidophosphoribosyltransferase (GPAT) (B) and carbamoyl phosphate synthetase II (CPSII) (C) activity in shCTRL and shENO1 PT45 and T3M4 cell lines. (D) Analysis of mitochondrial respiratory chain complex I and complexes II-IV activity in shCTRL and shENO1 PT45 and T3M4 cells, expressed as nmol NAD + /min/mg mitochondrial protein for complex I, nmol Cyt c reduced/min/mg mitochondrial proteins for complexes II-III and nmol Cyt c oxidized/min/mg mitochondrial protein for complex IV. (E) Analysis of ATP production in shCTRL and shENO1 PT45 and T3M4 cell lines. All the graphs illustrate the mean result of three independent experiments ± SEM. *p < 0.05; **p < 0.01;***p < 0.001 relative to shCTRL. (F) Transcript analysis of proteins involved in catabolic pathways/ mitochondrial biogenesis in CFPAC-1 (red), PT45 (orange), T3M4 (purple), MDA-MB-231 (blue) and NCI-H441 (green) shENO1 compared to shCTRL (white) cells. Results are the mean ± SEM of triplicates. *p < 0.05; **p < 0.01;***p < 0.001 relative to shCTRLtransduced cells. 
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Supplementary
MATERIAL AND METHODS
Viral Transduction
Lentiviral infections were performed using HEK293T cells as producers of viral supernatants. HEK-293T cells were grown on 10-cm plates to 70% confluence and co-transfected with shRNA lentiviral DNA and the helper vectors pCMV∆8.74 and pVSV-G (Clonetech) using the calcium phosphate precipitation method. The medium was harvested 24 hr post-transfection and filtered through a 0.45 μm filter. Supernatants from HEK-293T cultures were used to cross-transduce cancer cells in the presence of 8 μg/mL Polybrene (Sigma-Aldrich), and subsequent clones were selected by puromycin (2 μg/mL). 
Quantitative RT-PCR
Total RNA was extracted using the RNeasy Mini kit (Qiagen) and reverse transcription was performed from 2 µg of total RNA using iScript cDNA synthesis kit (BioRad) according to the manufacturer's instructions. Quantitative RT-PCR was performed using SYBR Green dye (Life Technologies) on a Thermal iCycler (BioRad). PCR reactions were performed in triplicate and the relative amount of cDNA was calculated by the comparative C T method using β-actin RNA sequences as a control. Data are represented as mean ± SEM of three or more independent experiments.
Oligonucleotide primer sequences for SybrGreen qRT-PCR
Gene
Sense Antisense   ENO1  GCCTCCTGCTCAAAGTCAAC  AACGATGAGACACCATGACG  ENO2  AGTGGACCACATCAACTCCACCAT  ACTCCAGCATCAGGTTGTCCAGTT  ENO3  CTCCCATGCTGGAAACAA  TGGCATCCTTCCCATACT  C-MYC  CTCCACTCGGAAGGACTAT  TTGTGTGTTCGCCTCTTG  AKR1C2  GCGTTGCCAGCTCATTGCTCTTAT  AATCCCAGGACAGGCATGAAGTGA  AKR1C1  GCTTTAGAGGCCACCAAATTGGCA  ACTGCCATCTGCAATCTTGCTTCG  AKR1B2  ACACCAGAACGCATTGCTGAGAAC  AGGTACAGCTCAACAAGGCACAGA  HK2  TGCAGCGCATCAAGGAGAACAAAG  ACGGTCTTATGTAGACGCTTGGCA  PFKL  AGTATACGTGGTGCACGATGGCTT  TGCGGATGTTCTCCACAATGGACT  EDH2  CCGGTGGAAGCATTTAGAG  GAATGACGGATGGATGGATG  NNMT  ATGCGCTCAAGAGCAGCTACTACA  CGTTGTTGGCCATGGTGGAAGAAT  CSNK2A1  AGGCAGGAAGAAAGGAAGGAAGGA AGACACACTTCCACAAGAGCCACT  FAH  TCGGAAGTGTGCATTCATCTCCCA  TCAACGCATTCTCCTTGTCCCTGA  FABP5  ACAGTTCAGCAGCTGCAAGGAAGA  ATACAATCTGGCTTGGCCATTGCG  MBOAT7  TTGGGCAAATTCCCTTTCT  CTTCCTTCCAAGTCTGCAATA  SQSTM1  AAATGGGTCCACCAGGAAACTGGA  TCAACTTCAATGCCCAGAGGGCTA  NCEH1  CGCTATGTCATGGTGAAGTAT  CAAGAGGGATGTCCAGTTTAG  ACADVL  AGAGGCATCATTGCTAAGGCGGTA  TCTCCTGGATCAGCCCAAAGTTGT  PFAH1B3  CGTGGCTGACAGCAAAGATAAGGA  CCGTCACCACCAATGCCAAAGTTA  HIBCH  ATAAAGGGAGCAGGAGGAAAGGCT  GGTTTCTGGCAAGAACCAACAGCA  AMPK1  CGTGTACGAAGGAAGAATCC  GAGTAGCAGTCCCTGATTTG  PGC1alpha  GAGGGAAAGTGAGCGATTAG  GTGAGGCTGATGTGTACTG  LKB1  GTCACCCTCTACAACATCAC  GTACTCAAGCATCCCTTTCA  beta ACTIN CGCCGCCAGCTCACCATG CACGATGGAGGGGAAGACGG
Western blot analysis
After SDS-PAGE, proteins were transferred to Hybond-N Nitrocellulose membrane (GE Healthcare Bio-Sciences). Membranes were blocked in Trisbuffered saline (TBS) containing 5% non-fat dry milk and 0.1% Tween 20 (TBS-T), before incubation with the primary antibody overnight at 4°C. Membranes were then washed with TBS-T followed by exposure to the appropriate horseradish peroxidase-conjugated secondary antibody for 1 hr, and then visualized using the enhanced chemiluminescence (ECL) detection system (GE Healthcare Bio-Sciences) by ProXPRESS 2D (PerkinElmer) scanning. The following antibodies were used: α-enolase mAb clone 72/1 (1), enolase (H300, Santa Cruz Biotechnology), β-actin (A2066, Sigma-Aldrich), c-Myc (GT168, GeneTex), p62/SQSTM1 (N3C1, GeneTex), ATG4B (GeneTex), ATG4D (N3C3, GeneTex), Sirt1 (19A7AB4, Abcam) phospho-Tyr15-cdc2 (9111, Cell Signaling), phospho-Ser807/811-Rb (8516, Cell Signaling), phospho-Ser345-Chk1 (2348, Cell Signaling), phospho-Thr68-Chk2 (2661, Cell Signaling), phosphoSer15-p53 (9284, Cell Signaling), Cyclin D1 (2926, Cell Signaling), Cyclin D3 (2936, Cell Signaling). LC3-II was enriched and quantified by Western blot analysis using LC3-II Enrichment Kit (Merck Millipore) according to the manufacturer's instructions.
Trypsin digestion and desalting
Cell pellets were resuspended in 200 µL of 8 M urea, and the protein concentration was measured by the Bradford Assay (BioRad). Proteins were transferred to a 1.5-mL eppendorf tube, reduced by 10 mM dithiothreitol (DTT) for 30 min at 37°C, and then alkylated by 50 mM iodoacetamide for 20 min at room temperature. The concentrated urea in the sample was diluted to a final concentration of 2 M, and the proteins were digested by trypsin at 37°C for 6 hr in a buffer containing ammonium bicarbonate (50 mM, pH 9). The digestion mixture was then acidified by adding glacial acetic acid to a final concentration of 2% and desalted by ZipTip (Millipore).
Tandem mass spectrometry analysis
Peptides were analyzed by highly sensitive reversed-phase liquid chromatography coupled nanospray tandem mass spectrometry (LC-MS/MS) using an LTQOrbitrap mass spectrometer (Thermo Fisher) (2) . Briefly, the reversed-phase LC column was slurry-packed inhouse with 5 μm, 200 Å pore size C 18 resin (Michrom BioResources) in a 100 µm i.d. × 10 cm long piece of fused silica capillary (Polymicro Technologies) with a laser-pulled tip. After sample injection, the column was washed for 5 min with mobile phase A (0.1% formic acid), and peptides were eluted using a linear gradient of 0% mobile phase B (0.1% formic acid, 80% acetonitrile) to 50% B in 160 min at 200 nL/min, then to 100% B in an additional 10 min for proteomics analysis. The LTQOrbitrap mass spectrometer was operated in a datadependent mode in which each full MS scan (60,000 resolving power) was followed by eight MS/MS scans where the eight most abundant molecular ions were dynamically selected and fragmented by collision-induced dissociation (CID) using a normalized collision energy of 35%. The Dynamic Exclusion Time was 30 s, and the Dynamic Exclusion Size was 200. The "FT master scan preview mode", "Charge state screening", "Monoisotopic precursor selection", and "Charge state rejection" were enabled so that only the 1 + , 2 + , and 3 + ions were selected and fragmented by CID.
Mass spectrometry data analysis
Tandem mass spectra collected by Xcalibur (version 2.0.2) were searched against the NCBI human protein database using SEQUEST (Bioworks software from ThermoFisher, version 3.3.1) with full tryptic cleavage constraints, static cysteine alkylation by iodoacetamide, and variable methionine oxidation. Mass tolerance for precursor ions was 5 ppm and mass tolerance for fragment ions was 0.25 Da. The SEQUEST search results of proteomics data were filtered by the criteria "Xcorr versus charge 1.9, 2.2, 3.0 for 1 + , 2 + , 3 + ions; ∆Cn > 0.1; probability of randomized identification of peptide < 0.01". Confident peptide identifications were determined using these stringent filter criteria for database match scoring followed by manual evaluation of the results. The "false discovery rate (FDR)" was estimated by searching a combined forward-reversed database as described by Elias (3) . The SEQUEST search results were exported to Excel files and compared. Spectra count label-free quantitation analysis was performed applying the formula: Relative difference (%) = [(Total no. peptides in shENO1)-(Total no. peptides in shCTRL)]/ [(Total no. peptides in shENO1 + Total no. peptides in shCTRL)/2]*100.
Glucose uptake
The uptake of glucose was measured by radiolabeling cells with 0.3 µCi/ml 2-deoxy-D-[
3 H]-glucose, as described earlier (4) insulin increases cyclic GMP production by inducing nitric oxide (NO). The non carrier-mediated glucose uptake was measuring by performing the assay in the presence of 10 µM cytochalasin B, a strong inhibitor of the facilitated glucose uptake. Results were expressed as pmol 2-deoxy-D-[ Aldose reductase activity Cells were washed with PBS, detached by gentle scraping, centrifuged at 13,000 × g for 5 min at 4°C, re-suspended in 0.4 mL of 50 mmol/L Na 3 PO 4 buffer (pH 7.0). A 50 μL aliquot was sonicated and used for determining the cell proteins. The remaining sample was transferred to a 96-well plate, in the presence of 10 mmol/L glucose, dissolved in Na 3 PO 4 buffer. 1.5 mmol/L NADPH was added. The rate of NADPH oxidation was followed for 6 min, monitoring the absorbance at 340 nm with a Packard microplate reader EL340 (Bio-Tek Instruments). Results were expressed as nmol NADP + produced/min/mg cell proteins.
NADPH oxidase activity
NADPH oxidase activity was carried out in vitro by the isoluminol-chemiluminescence assay. A total of 2 × 10 6 cells was washed with PBS, detached with trypsin/EDTA (0.05/0.02% v/v), re-suspended in 1 mL PBS containing 7.5 mmol/L glucose, 0.9 mmol/L CaCl 2 , 0.5 mM MgCl 2 , and incubated for 10 min at 37°C, in the presence of 200 ng/mL phorbol myristate acetate (PMA) to activate the enzyme, 125 μmol/L isoluminol, 25 U/mL horseradish peroxidase. A 50 μL aliquot was sonicated and used for determining the cell proteins. Chemiluminescence of each sample derived from superoxide and lucigenin was detected using a Synergy HT microplate reader (Bio-Tek Instruments) and was expressed as relative luminescence unit (RLU)/ mg cell proteins. For the negative control, in each experiment, one sample was treated with 450 U/mL superoxide dismutase (SOD): the detected chemiluminescence was < 5% of the corresponding sample in the absence of SOD (not shown).
Tyrosine catabolism
Determination of phenylalanine and acetoacetate levels was performed according to the instruction manuals of EnzyChrom TM phenylalanine and ketone body assay kits (BioAssay Systems).
Glutamine catabolism
Glutamine catabolism was measured as reported (5) , with minor modifications. Cells were washed with PBS, detached by gentle scraping, centrifuged at 13,000 × g for 5 min at 4°C, re-suspended in 250 µL of buffer A (150 mmol/L KH 2 PO 4 , 63 mmol/L Tris/HCl, 0.25 mmol/L EDTA; pH 8.6) and sonicated. The intracellular protein content was measured using the BCA kit (SigmaAldrich). A volume of 100 µL of the whole cell lysates was incubated for 30 min at 37°C in a quartz cuvette, in the presence of 50 µL of 20 mmol/L L-glutamine and 850 µL of buffer B (80 mmol/L Tris/HCl, 20 mmol/L NAD + , 20 mmol/L ADP, 3% v/v H 2 O 2 ; pH 9.4). The absorbance of NADH was monitored at 340 nm using a Lambda 3 spectrophotometer (PerkinElmer). The kinetics was linear throughout the assay. The results were expressed as µmol NADH/min/mg cell proteins, and were considered as an index of the activity of glutaminase (GLS) plus L-glutamic dehydrogenase. In a second series of samples, 20 µL of the GLS inhibitor bis-2-(5-phenylacetamido-1,3,4-thiadiazol-2-yl)ethyl sulfide BTPES (30 µmol/L) was added after 15 min. This concentration was chosen as it produced 100% inhibition of glutaminase activity in our system (not shown). The absorbance of NADH was monitored for 15 min as described previously. The results, considered as an index of the activity of L-glutamic dehydrogenase, were expressed as µmol NADH/min/mg cell proteins. GLS activity was obtained by subtracting the rate of the second assay from the rate of the first one.
Purine synthesis
